Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human fibrin sealant for hemostasis in minimally invasive orthopedic surgery incisions
CTR20222719Phase 3Suspended
- Sponsor
- Pacific Shuanglin Bio-pharmacy
- Start
- Nov 2022
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of tachosil, sponsored by Pacific Shuanglin Bio-pharmacy. Started Nov 2022; status: suspended.
02
Drugs
tachosil
Beyond the preview
Go deeper on CTR20222719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222719.